The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company offers subscription-based membership programs, software and data-enabled services. All of its programs are rooted in best practices and extends across four areas, including Best practices research, Technology, Data-enabled services and Consulting services. The best practices research and insight programs provide the foundation for all of its other programs. The Company offers technology analytics programs anchored by cloud-based software applications that surface performance improvement opportunities to accelerate progress. Through its consulting services, the Company provides on-the-ground support for performance improvement initiatives, as well as best practice professional management of areas of the hospital or medical group. The Company's data-enabled services are primarily focused in the area of enrollment management.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryResearch & Consulting Services
SectorN/A
Phone+1-202-2665600
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableOptionable
The Advisory Board (NASDAQ:ABCO) Frequently Asked Questions
What is The Advisory Board's stock symbol?
The Advisory Board trades on the NASDAQ under the ticker symbol "ABCO."
How were The Advisory Board's earnings last quarter?
The Advisory Board Company (NASDAQ:ABCO) issued its earnings results on Wednesday, July, 27th. The business services provider reported $0.47 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.34 by $0.13. The business services provider earned $198.40 million during the quarter, compared to analysts' expectations of $196.49 million. The Advisory Board's quarterly revenue was up 7.4% on a year-over-year basis. During the same period in the previous year, the company earned $0.40 EPS. View The Advisory Board's Earnings History.
Has The Advisory Board been receiving favorable news coverage?
News coverage about ABCO stock has been trending somewhat positive recently, InfoTrie Sentiment reports. InfoTrie rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. The Advisory Board earned a coverage optimism score of 1.9 on InfoTrie's scale. They also assigned news stories about the business services provider a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the next few days.
What other stocks do shareholders of The Advisory Board own?
Who are The Advisory Board's key executives?
The Advisory Board's management team includes the folowing people:
- Robert W. Musslewhite J.D., Chairman of the Board, Chief Executive Officer (Age 47)
- David L. Felsenthal, President, Director (Age 46)
- Michael T. Kirshbaum, Chief Financial Officer, Treasurer (Age 40)
- Richard A. Schwartz Ph.D., Chief Operating Officer - Health Care (Age 51)
- Cormac F. Miller, Chief Product Officer (Age 43)
- Mary D. Van Hoose, Chief Talent Officer (Age 52)
- Evan R. Farber, Chief Legal Officer and Corporate Secretary (Age 44)
- Kelt Kindick, Lead Independent Director (Age 62)
- Sanjeev K. Bansal, Independent Director (Age 51)
- Peter J. Grua, Independent Director (Age 63)
What is The Advisory Board's stock price today?
One share of ABCO stock can currently be purchased for approximately $53.8250.
What is The Advisory Board's official website?
How can I contact The Advisory Board?
The Advisory Board's mailing address is 2445 M St NW, WASHINGTON, DC 20037-1435, United States. The business services provider can be reached via phone at +1-202-2665600 or via email at [email protected]
MarketBeat Community Rating for The Advisory Board (NASDAQ ABCO)
MarketBeat's community ratings are surveys of what our community members think about The Advisory Board and other stocks. Vote "Outperform" if you believe ABCO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ABCO will underperform the S&P 500 over the long term. You may vote once every thirty days.
